Access to Medicines and Globalization Issues
29 october - 29 october
During the event, we will talk about:
- the impact of the global funding crisis on access to treatment and the role of intellectual property and patent monopolies on medicines;
- the new U.S. tariff policy and changes in the international approach to intellectual property;
- breakthroughs in biomedical developments against HIV and how intellectual property determines access to these technologies;
- the support of local pharmaceutical production by international donors and the challenges of limited funding.
Who will find it interesting:
- scientists and researchers developing new projects in biomedicine, pharmacy, or technology;
- medical professionals and bioethicists seeking to understand the legal aspects of their work;
- lawyers and patent attorneys working with intellectual property in the medical field;
- startups, innovators, and entrepreneurs developing health-related technologies;
- students and educators studying law, biology, medicine, technology, or ethics;
- anyone interested in how science and technology influence humanity, society, and human rights.
Moderator: Oksana Kashyntseva, PhD in Law, Associate Professor, Adviser to the Director of UANIPIO, National Consultant of UNDP in Ukraine, Consultant to the WHO Country Office in Ukraine, National Consultant of the Council of Europe, and Member of the European Association of Health Law.
An online interview within the project «Law, Medicine, Ethics: Points of Intersection», during which participants, together with experts, will discuss the legal, ethical, and biotechnological challenges associated with genetic changes that can affect human life, science, and society.
Participants will have the opportunity to:
- discuss ethical and legal challenges in the field of biomedicine;
- ask questions to experts and join a professional dialogue;
- explore new aspects of the interaction between law, science, and morality in healthcare.
Course speakers
Course speakers
Do you want to know more?
We are here to answer any questions you may have.